Cannabidiol (CBD) oral solution

DRUG3 trials

Sponsors

The University of Texas Health Science Center at San Antonio, Florida A&M University, UMC Utrecht

Conditions

Diabetic NeuropathiesDiabetic Peripheral Neuropathic Pain (DPN)EpilepsyPosttraumatic Stress DisorderRefractory EpilepsyRefractory Epilepsy in ChildrenStress Disorders, Post-Traumatic

Phase 1

Enhancing Prolonged Exposure With Cannabidiol to Treat Posttraumatic Stress Disorder

CompletedNCT05132699

The University of Texas Health Science Center at San AntonioPosttraumatic Stress Disorder, Stress Disorders, Post-Traumatic

Start: 2022-04-04End: 2023-06-30Updated: 2024-10-10

Cannabidiol for the Treatment of Diabetic Peripheral Neuropathy: Pilot Study

RecruitingNCT07298408

Florida A&M UniversityDiabetic Neuropathies, Diabetic Peripheral Neuropathic Pain (DPN)

Start: 2026-04-02End: 2027-06-30Target: 20Updated: 2026-04-29

Phase 3

Cannabidiol as add-on Therapy for Children With Refractory Epilepsy (CBD-uN1que), a High-quality Individualized Approach: a Series of N-of-1 Trials

RecruitingNCT07668856

UMC UtrechtEpilepsy, Refractory Epilepsy, Refractory Epilepsy in Children

Start: 2025-02-06End: 2027-12-01Target: 50Updated: 2026-06-25